Latest News & Features
Americas
US-based law firm Ropes & Gray has promoted two to partner roles in its life science practice in New York. 4 November 2014
Americas
A case that was expected to act as a benchmark for future patent cases in Canada has been settled a day before the country’s Supreme Court was due to hear arguments. 4 November 2014
Biotechnology
Earlier this year, the Advocate General of
the CJEU opined that stem cells from parthenotes are patentable. Franz-Josef Zimmer and Markus Grammel examine the reasoning behind his opinion. 4 November 2014
Big Pharma
Depositing a microorganism in a country may be crucial for obtaining a method patent in that jurisdiction, but can come with its pitfalls, says Peter ten Haaft. 4 November 2014
Americas
Protecting rights related to desirable plant species is a delicate process, says Gabriel Di Blasi. 4 November 2014
Americas
Canada’s highest court is set to hear a hotly anticipated dispute pitting generic company Apotex against drug companies Sanofi and Bristol-Myers Squibb (BMS). 3 November 2014
Americas
Biotechnology company Amgen has filed a lawsuit against Sanofi and Regeneron Pharmaceuticals accusing the pair of infringing three patents. 3 November 2014
Americas
Jason Rutt considers the impact AstraZeneca’s recent US pay-for-delay case will have on the industry. 3 November 2014
Big Pharma
The current outbreak of Ebola has devastated communities in West Africa. It has also thrown a light on the complex web of IP rights surrounding the possible treatments for this serious and usually fatal virus, as LSIPR discovered. 3 November 2014
Americas
AstraZeneca has had a tough few years, with a clutch of patent expiries one of the most serious of its problems. So where does it go from here? To find out, LSIPR spoke to the Anglo-Swedish pharmaceutical company’s vice president of business development about the role IP is playing in its plans for future success. 3 November 2014